Press Release for the First Quarter ended June 30, 2026, Results
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 30 Jul 2026, 06:23 PM IST · BSE ID: 60a93dc2-6326-4513-9787-f7b64b311f38
View Original BSE Filing (PDF)
💡
In Simple Terms
Global Health's Q1 FY27 total income grew by 26.2%, though profit after tax slightly decreased compared to last year.
🤖 AI Summary
- Global Health's consolidated Total Income for Q1 FY27 was INR 13,262 million, an increase of 26.2% year-on-year.
- EBITDA ex-Noida reached INR 3,201 million, showing a 23.9% year-on-year growth with 25.8% margins.
- Profit After Tax for Q1 FY27 stood at INR 1,573 million, marking a 1.1% decrease year-on-year.
- The company operationalized 72 new beds during the quarter, with 51 in Noida and 21 in Lucknow.
- The Guwahati hospital project has been scaled up to a 650-bedded super specialty hospital with a capex of INR 9,700 million.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Consolidated Total Income Q1 FY27
INR 13,262 million
26.2%
Consolidated EBITDA Q1 FY27
INR 3,153 million
23.5%
Consolidated Profit after tax Q1 FY27
INR 1,573 million
-1.1%
Operational Beds (Census) Q1 FY27
3,037
22.1%
ARPOB Q1 FY27
INR 70,244
5.5%
🏢 How This Affects the Company
The company's Total Income growth and bed capacity expansion indicate an increase in service delivery and patient reach in its operating regions. Enhanced international patient revenue and OPD Pharmacy growth support diversified income streams.
Increased finance costs and depreciation/amortisation expenses, alongside a non-recurring exceptional income in the prior year, contributed to a marginal decrease in Profit After Tax despite revenue growth. Noida hospital's reduced EBITDA loss indicates improving operational efficiency for newer facilities.
The addition of 72 beds and onboarding of over 70 doctors strengthens the company's operational capacity and clinical capabilities across its network. Increased occupied bed days and improved ARPOB also reflect operational efficiency gains.
No specific new risks were highlighted in the filing; however, increased finance costs and significant capex for projects like Guwahati introduce capital expenditure and financing risks.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected as the company's financial performance and strategic expansion plans for new hospitals influence its long-term operational and financial health.
🔍
Management Signal
Management is focused on revenue growth, operational efficiency through bed expansion, reducing losses in newer units, and significant long-term capital investment in new hospital projects.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 results — monitor continued growth in Total Income and PAT.
Noida hospital performance — assess further reduction in EBITDA losses.
Indore cancer facility launch — track operationalization of 80 new beds.
LOW RISK
The filing indicates growth across key metrics, with no new significant risks disclosed.
💡 Investor Takeaway
Global Health Limited reported Q1 FY27 consolidated Total Income of INR 13,262 million, up 26.2% year-on-year. EBITDA (ex-Noida) grew 23.9% to INR 3,201 million. Profit After Tax was INR 1,573 million, a 1.1% decrease compared to Q1 FY26, which included a non-recurring exceptional income of INR 196 million.
⚖️ Strengths & Concerns
✅ Positives
- Consolidated Total Income grew 26.2% year-on-year to INR 13,262 million, indicating robust revenue expansion.
- EBITDA ex Noida increased 23.9% year-on-year to INR 3,201 million, with margins of 25.8% for Q1 FY27.
⚠️ Concerns
- Profit After Tax decreased 1.1% year-on-year to INR 1,573 million, partly due to a non-recurring exceptional income in Q1 FY26.
- EBITDA Margins for Q1 FY27 were 23.8%, a 51 basis points decline compared to 24.3% in Q1 FY26.
📅 Company Track Record
Global Health Limited reported Q4 FY26 total income growth of 25.3% to INR 11,958 million. Q1 FY27 standalone PAT was INR 1,373.07 million, with Guwahati hospital beds previously stated to increase to 650, now confirmed in the press release.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Global Health Limited's consolidated Total Income in Q1 FY27?
Global Health Limited reported a consolidated Total Income of INR 13,262 million for the first quarter ended June 30, 2026, marking a 26.2% year-on-year increase.
What was Global Health Limited's Profit After Tax in Q1 FY27?
Profit After Tax for Global Health Limited in Q1 FY27 was INR 1,573 million, which is a 1.1% decrease compared to INR 1,590 million in Q1 FY26.
How many new beds did Global Health Limited add in Q1 FY27?
During Q1 FY27, Global Health Limited added a total of 72 new beds across its network, with 51 beds in Noida and 21 beds in Lucknow.
What is the updated plan for Global Health's Guwahati project?
The Guwahati project has been scaled up to a 650-bedded super specialty hospital with a total capital expenditure of INR 9,700 million, following new bye-laws and construction standards.
What was the EBITDA for Global Health Limited (excluding Noida) in Q1 FY27?
EBITDA for Global Health Limited, excluding Noida, was INR 3,201 million in Q1 FY27, representing a 23.9% year-on-year increase with margins of 25.8%.
Questions based on this BSE filing only. For information purposes.